Background. Since indications for liver transplantation (LTx) have increased and the shortage of brain dead transplant organs continues, an increase in deaths related to extended waiting periods can be documented. Living-related LTx (LRLTx) is a good alternative that can help compensate the shortness of organs for transplantation and can reduce waiting periods and deaths related to a long waiting list. We started a LRLTx programme at the transplantation centre, Department of Surgery at the University of Heidelberg to increase our transplantation activities. In this article we present our primary experiences and protocol. Methods. From September 2002 to June 2003, three LRLTx were performed. Indications in recipients were hepatocellular carcinoma in two cases and liver cirrhoses due to hepatitis B in one patient. Two patients received the right liver (segments V-VIII) of their donors. One patient received the complete liver collected as a Domino LTx. All liver transplants were performed without the use of a venous bypass. Results. The peri-and post-operative courses of our donors were without complications, except for an infected intraabdominal bilioma, which was drained interventionally. The donors were fully able to work after the operation. The coordinative and logistical work should not be underestimated. Conclusions. This therapy should only be offered and performed in centres with excellent expert knowledge in liver and transplantation surgery.
Introduction
Forty years have passed since the first liver transplantation (LTx) was performed successfully by T. E. Starzl. In the last two decades this operation has been established as the standard therapy for end-stage liver diseases. By optimizing immunosuppression, operation techniques, the peri-and post-operative management as well as the intense research on the understanding of the pathophysiology of ischaemia and reperfusion injury, the 1 and 5 year survival could be increased to 73 and 67%, respectively, with a good quality of life [1] . At the moment we notice the problem that through an increase in indications for LTx and a reduction in donors for brain dead transplants the deaths related to long waiting times for LTx increase in number. Through further development of surgical techniques, as well as the anaesthesiological and intensive care, therapy options such as living-related LTx (LRLTx) could be established. This method increases the number of LTx and supports the increased number of indications for LTx. Since the first LRLTx was performed in 1988, more than 60 centres in the USA, Europe and Asia have established such a programme. Presently, a total of about 2500 LRLTx have been carried out [2] . After the necessary learning phase, 1 year survival rates between 88 and 95% and 5 year survival rates ranging from 81 to 89% can be accomplished. In 3-7% of children and in 13% of adult patients a retransplantation is necessary. The long-term results with biliary and vascular complication rates of 22 and 9.8%, respectively, in adults and of 0-7 and 8%, respectively, in children are quite acceptable [1, [3] [4] [5] .
To extend our transplantation activities we started a LRLTx programme at our transplantation centre at the Department of Surgery at the University of Heidelberg. In this paper, we want to present our first experiences in establishing this programme, guidelines and first patient data.
Basic requirements of the centre
We suggest LRLTx programmes should only be established in 'high volume centres' concerning hepatobiliary surgery (liver resection) and LTx. The following are the most important criteria that should be met:
(1) Long-term experience in hepato-, pancreato-and biliary surgery with an adequate caseload and a minimum number of liver operations (>50 liver resections per year 
Disadvantages for the donor:
Healthy donor becomes a patient. Real volunteers (without emotional or social pressure). Post-operative morbidity and mortality due to wound infections, pneumonia, intra-abdominal abscesses, bleeding, biliary leak, liver dys-or nonfunction. Questions concerning insurance and social security.
Disadvantages for the recipient:
Maintenance of a partial organ. Seriously ill patient. Surgical morbidity and mortality. Unclear long-term prognosis.
After the donor has agreed to the LDLTx and a thorough education has been completed by a staff member, careful evaluation of the health status is performed. This procedure usually requires about 6 weeks and can be performed stepwise in an ambulatory setting. Included in this testing are the donor history, physical examination, blood tests including liver enzymes and hepatitis serology, resting and stress ECG, heart echocardiogram, chest X-ray, functional respiratory parameters, CT and CT angiography. In addition, we perform computer-based surgery planning by 3D-CT reconstruction of the liver including arteriovenous vascular system and bile ducts to do size-matching and verification of vascular variations before LDLTx. The importance of this procedure is displayed by Hiroshige et al. [8] . The detection of vascular variation is essential for the donor and recipient. The range of possible variations in this area is elucidated by a study with 107 adult potential liver donation candidates, performed at Johns Hopkins University; 65% of the evaluated persons presented 129 vascular variations that were surgically relevant (important for the donor, 37; for the recipients, 27; for both, 65) [9] . The potential resection line is discussed in a team approach with radiologists. Liver biopsy and histopathological evaluation are performed in eligible donors after a psychological evaluation and examination, if necessary. Anaesthesiologists recommend that the donor should donate blood for autotransfusion before surgery.
After the above-mentioned data have been collected, the donor is invited by the ethical commission to check whether the decision for partial liver donation was completely voluntary. A 2 week consideration time is then provided for. At the end of this procedure, the informed consent of the donor is obtained. In Figure 1 the Heidelberg Evaluation Algorithm is summarized, and in Figure 2 Table 1 Establishing a living-donation liver transplantation programme iv3
and the complete hepatectomy in the Domino donor as well as the implantation of the organs in the receivers were performed as previously published [10, 11] . In our patients, the implementation of the venous bypass, which would increase the risk of morbidity (thrombosis, renal failure, blood coagulation disorders), was not necessary. We support the opinion of Fan et al. [12] that in performing an adequate total hepatectomy with sparing of the inferior caval vein, a tangential clamping of the inferior caval vein is sufficient and a bypass is not necessary.
In Table 2 the most important data concerning gender, grade of kinship, peri-and post-operative data and complications are noted. If we compare our intraoperative data on surgery time, blood loss and the substituted amount of blood to the data of 30 LDLTx patients from the literature, who only have left-sided lobectomy or left lateral lobectomy [13] , we can underline the excellent peri-and post-operative course of our donor surgery (short times of surgery, minimal blood loss, very short times in the ICU). This can be accomplished because of the above-mentioned expert knowledge of liver resection in the centre. To guarantee a secure post-operative course we kept our patients a little longer in the hospital instead of watching them in an ambulatory setting. In the first donor, an intraabdominal bilioma occurred on the seventh postoperative day that was treated with an interventional drainage. Otherwise, the post-operative course was without complication (Table 2 ). All three donors are fully able to work and they are totally integrated in their work. Adequate liver regeneration could be documented in the post-operatively performed CTs after 24 weeks. A normal liver function could be found in the subsequent follow-ups after 9, 7 and 5 months in all donors, respectively.
In two patients the indication for transplantation was hepatocellular carcinoma (HCC) and in one patient it was liver cirrhoses due to hepatitis (Table 3) . Our indications were in accordance with the indications found in the literature [1] . As expected, the duration of surgery was longer, showing the learning curve in the beginning of our LDLTx programme (the Domino transplantation with a surgical time of 3 h and 40 min is not considered). Peri-operative blood loss and the amount of substituted blood were acceptable. The longer ICU stay of LDLTx patients compared with 2 or 3 days in conventional LTx can be explained by the post-operative arterial complications that required surgical revision (Table 3 ). The increasing use of microsurgical techniques reduces the technique-related morbidity. It has been shown that optimization of the results and overcoming the learning curve can be accomplished in centres with a caseload of more than 40 LDLTx per year [14, 15] .
Coordination and logistical aspects
The coordinating and logistic efforts should not be underestimated. To perform LDLTx in an adequate manner two complete and experienced teams of liver surgeons and two experienced anaesthesiological teams as well as OR nurses are required. Also, two well equipped ORs for LDLTx are necessary. Since costeffective treatment and DRGs are actually important components of medical treatment, ensuring the necessity of performing a high number of surgeries, the blocking of two ORs would not be acceptable. Under these conditions, this can only be avoided by planning LDLTx on weekends or holidays.
Conclusion
LDLTx is a good alternative to manage today's shortness of donor organs and to reduce time on the waiting list as well as deaths related to long waiting times. Due to the present risk of morbidity and mortality, intensive and careful evaluation, as well as strict selection of the living donors, should be performed by an experienced team. It still has to be evaluated if it is ethically correct to turn a healthy person into a sick patient by performing a living donation. The mortality and the present minimal risk cannot be neglected, even after strict selection of the donor. During the evaluation process of the patient the potential post-operative complications (liver failure, bleeding, biliary leaking and fistulas) have to be discussed extensively. Also, the donor has to know about the post-operative reduction of his quality of life. Concerning the long-term consequences following LDLTx, it seems that extra coverage by health insurance is necessary. Last but not least, the background of the willingness to donate an organ should be carefully elucidated. The long-term course of LDLTx has also to be analysed in prospective multicentric studies. Until now, short-term observations report 30% biliary complications (fistula, stenosis and strictures). LDLTx should only be performed in patients with end-stage liver disease or HCC. The collected experiences in Split LTx and LDLTx have shown that this therapeutic option could only be established and offered in centres with sufficient experience in liver and transplantation surgery.
